维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="Wursthorn"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective显示文摘	Jerzy Jaroszewicz Beatriz Calle Serrano Karsten Wursthorn Katja Deterding Jerome Schlue Regina Raupach Robert Flisiak C.-Thomas Bock Michael P. Manns Heiner Wedemeyer Markus Cornberg	2010	Journal of Hepatology2010，，4：	6
2	Kinetics of he-patitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients显示文摘	WURSTHORN K JUNG M RIVA A	2010	Hepatology2010，52，5：	1
3	Kinetics of Hepatitis B Surface Antigen Decline During 3 Years of Telbivudine Treatment in Hepatitis B e Antigen-Positive Patients显示文摘	Wursthorn K Jung M Riva A et at	2010	Hepatology2010，52，5：	1
4	Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B显示文摘	Wursthorn K Lutgehetmann M Dandri M		0，，03：	1
5	Economic-environmental monitoring indicators for European countries:A disaggregated sector-based approach for monitoring eco-efficiency 显示文摘	SIBYLLE Wursthorn Witold-Roger PoganietzLiselotte Schebek	2011	Ecological Economics2011，70，3：	1
6	Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus(HBV)-infeetion: a European perspective显示文摘	Jaroszewicz J Calle Serrano B Wursthorn K		J Hepatol0，52，4：	1
7	Hepatitis B surface anti- gen (HBsAg) levels in the natural history of hepatitis B virus (HBV)- infection: a European perspective 显示文摘	Jaroszewicz J Calle SB Wursthorn K	2010	J Hepatol2010，52，4：	1
8	Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo显示文摘	Paulk N K Wursthorn K Wang Z	2010	Hepatology2010，51，4：	1
9	Peginterferonα-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B显示文摘	Wursthorn K Lutgehetmann M Dandri M Volz T Buggisch P Zollner B		Hepatology0，，：	1
10	Peginterferon alpha - 2b plus adefovir induce strong cccDNA decline and HB- sAg reduction in patients with chronic hepatitis B显示文摘	Wursthorn K Lutgehetmann M Dandri M	2006	Hepatolo- gy2006，44，3：	1
11	Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy显示文摘	Marcellin P Wursthorn K Wedemeyer H	2015	J Hepatol2015，62，1：	1
12	Rigid PVC:New developments for improving weatherability显示文摘	K R Wursthorn	1988	Journal of Vinyl Technology1988，10，1：	1
13	Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase dur- ing lamivudine therapy显示文摘	Zllner B Sterneck M Wursthorn K	2005	J Clin Microbiol2005，43，5：	1
14	Hepatitis B surface antigen (HBsAg) levels in the natural history of he- pa - titis B virus (HBV) - infection, a European perspective 显示文摘	JaroszewiczJ Calle Serrano BC Wursthorn K	2010	J Hepatol2010，52，4：	1
15	Peginterferon &lph&-2 b plus &defovir induce strong cccDNA decIine &nd HBsAg reduction in patients with chronic hep&titis B显示文摘	Wursthorn K Lutgehetm&nn M D&ndri M et &l	2006	Hep&tology2006，44，5：	1
16	Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus ( HBV ) -infection : a European perspective 显示文摘	Jaroszewicz J Serrano B C Wursthorn K	2010	Journal of hepatology2010，52，4：	1
17	Hepatitis B surface antigen(HBsAg) levels in the natural history of hepatitis B virus (HBV)-infeetion : a European perspeetive显示文摘	Jaroszewicz J Calle SB Wursthorn K	2010	J Hepatol2010，52，4：	1
18	Kinetics of hepatitis B surtace antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients 显示文摘	Wursthorn K Jung M Riva A	2010	Hepatology2010，52，5：	1
19	Republished pa per: Managing HBV in patients with impaired immunity显示文摘	Wursthorn K Wedemeyer H Manns MP	2011	Postgrad Med J2011，87，025：	1
20	Telbivudi- ne (LDT) plus peg -interferon (PEGIFN) in HBeAg -posi- tive chronic hepatitis B -Very potent antiviral efficacy but risk of peripheral neuropathy (PN) 显示文摘	MARCELLIN P AVlLA C WURSTHORN K	2012	J Hepatol2012，52，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示